Anixa Biosciences, Inc.
Chereen Abushaban has years of experience in office management, benefit administration, and client services. Chereen is skilled in organizing office operations, coordinating with various departments, and ensuring procedures are followed efficiently. Throughout their career, Chereen has demonstrated proficiency in handling accounts payable, scheduling, HR support, and maintaining office supplies. Their educational background includes a BA in Sociology from San Jose State University and an Associate's degree in Business Administration and Management from Evergreen Valley College.
This person is not in any teams
Anixa Biosciences, Inc.
Anixa Biosciences (NASDAQ:ANIX) is a clinical stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology. The company’s vaccine portfolio includes a novel vaccine being developed in collaboration with Cleveland Clinic to prevent breast cancer--specifically triple negative breast cancer (TNBC), the most lethal form of the disease--as well as a vaccine to prevent ovarian cancer. These vaccine technologies focus on immunizing against "retired" proteins that have been found to be expressed in certain forms of cancer. Anixa's unique business model of partnering with world-renowned research institutions on clinical development allows the company to continually examine emerging technologies in complementary fields for further development and commercialization.